Article Text

Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Subthalamic nucleus stimulation in Parkinson’s disease is associated with a risk of fixed epiglottis
  1. H Kataoka,
  2. Maya Yanase,
  3. Makoto Kawahara,
  4. Hidehiro Hirabayashi,
  5. Toshiaki Yamanaka,
  6. Makito Hirano,
  7. Satoshi Ueno
  1. Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634–8522, Japan
  1. hk55{at}naramed-u.ac.jp

Summary

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) alleviates motor disability of patients with Parkinson’s disease (PD). Mental changes and other adverse events are common, but typically transient. Severe complications such as intracerebral haemorrhage or infection are rare, but 6 of 73 patients who underwent STN-DBS died of pneumonia, cardiac failure or pulmonary embolism. We describe a patient with PD who had sudden respiratory difficulty due to a fixed epiglottis after STN-DBS. This symptom was confirmed to be related to STN stimulation on fibre-optic examination of the larynx.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.